← Leaderboards
Adrian M Piliponsky
Seattle Children'S Hospital
$10,682,375
Attributed
$14,914,561
Total exposure
7
Grants
6
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $2M · FY2012–25$2M$1.5M$1M$500K$0
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$14,914,561 · 7
By mechanism
R01$14,396,736 · 6
R21$517,825 · 1
Top collaborators
- Richard Goff James9 shared
- Lakshmi Rajagopal5 shared
Most similar at Seattle Children'S Hospital
Same institution · by research overlap
- Sihoun Hahn$9,588,424
- Lakshmi Rajagopal$23,879,900
Others in their field
Top investigators on “Play”
- Lawrence Corey · Fred Hutchinson Cancer Center$428,785,907
- Chanza Baytop · Westat, Inc.$271,217,917
- Richard K. Wilson · Washington University$200,435,757
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$196,976,947
- Jeffrey P Krischer · University Of South Florida$191,869,794
- Constance Ann Benson · University Of California, San Diego$187,132,366
Research focus
PlayIn VivoMediatingResponseCellsFutureInfectionMast CellBacterial InfectionsProteinsBaseImmuneComplexSignal TransductionCell PhysiologyCytokinePathogenReportingImmune ResponseMediator Of Activation ProteinImpairmentPreventFunctional DisorderMembrane Proteins
Grant awards (26)
Critical role for Solute Carrier Proteins (SLCs) for mast cell function$1,058,168
R01 · FY2025 · AI · contact PI
Elucidating and targeting Siglec-9 function on mast cells$612,917
R01 · FY2025 · AI · contact PI
FXIIIA production by mast cells for innate immunity$747,959
R01 · FY2024 · AI · contact PI
Critical role for Solute Carrier Proteins (SLCs) for mast cell function$734,048
R01 · FY2024 · AI · contact PI
FXIIIA production by mast cells for innate immunity$755,460
R01 · FY2023 · AI · contact PI
Critical role for Solute Carrier Proteins (SLCs) for mast cell function$750,025
R01 · FY2023 · AI · contact PI
FXIIIA production by mast cells for innate immunity$776,960
R01 · FY2022 · AI · contact PI
Critical role for Solute Carrier Proteins (SLCs) for mast cell function$521,208
R01 · FY2022 · AI · contact PI
Role of Dock8 in Mucosal Immunity$288,272
R01 · FY2022 · AI
Critical Role of Basophils in the Enhancement of the Innate Immune Response during Sepsis$735,264
R01 · FY2021 · HL · contact PI
FXIIIA production by mast cells for innate immunity$717,609
R01 · FY2021 · AI · contact PI
Role of Dock8 in Mucosal Immunity$288,600
R01 · FY2021 · AI
Critical Role of Basophils in the Enhancement of the Innate Immune Response during Sepsis$735,264
R01 · FY2020 · HL · contact PI
FXIIIA production by mast cells for innate immunity$715,119
R01 · FY2020 · AI · contact PI
Role of Dock8 in Mucosal Immunity$288,600
R01 · FY2020 · AI
New Approaches for the Identification of Critical Signals for Mast Cell Function$235,375
R21 · FY2020 · AI · contact PI
Critical Role of Basophils in the Enhancement of the Innate Immune Response during Sepsis$721,571
R01 · FY2019 · HL · contact PI
New Approaches for the Identification of Critical Signals for Mast Cell Function$282,450
R21 · FY2019 · AI · contact PI
Role of Dock8 in Mucosal Immunity$274,115
R01 · FY2019 · AI
Critical Role of Basophils in the Enhancement of the Innate Immune Response during Sepsis$768,772
R01 · FY2018 · HL · contact PI
Role of Dock8 in Mucosal Immunity$548,230
R01 · FY2018 · AI
Critical role of chymase in the regulation of inflammation and survival in sepsis$475,000
R01 · FY2016 · HL · contact PI
Critical role of chymase in the regulation of inflammation and survival in sepsis$467,875
R01 · FY2015 · HL · contact PI
Critical role of chymase in the regulation of inflammation and survival in sepsis$465,500
R01 · FY2014 · HL · contact PI
Critical role of chymase in the regulation of inflammation and survival in sepsis$452,200
R01 · FY2013 · HL · contact PI
Critical role of chymase in the regulation of inflammation and survival in sepsis$498,000
R01 · FY2012 · HL · contact PI